Activation and maturation of peripheral blood T cells in HIV-1-infected and HIV-1-uninfected adults in Burkina Faso: A cross-sectional study

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Tiba, Fabrice ^a   Nauwelaers, Frans ^b   Sangaré, Lassana ^c   Coulibaly, Boubacar ^d   Kräusslich, Hans Georg ^a   Böhler, Thomas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BD Biosciences ^*  (Belgium)

^c CENTRE HOSPITALIER UNIVERSITAIRE YALGADO OUÉDRAOGO   (Burkina Faso)

^d CENTRE DE RECHERCHE EN SANTÉ DE NOUNA   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; FAS ANTIGEN; CD38 PROTEIN, HUMAN; FAS PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BURKINA FASO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RURAL AREA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; URBAN AREA; VIRUS LOAD; BLOOD; CHEMISTRY; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; VIROLOGY;

ADULT; ANTIGENS, CD38; ANTIGENS, CD95; BLOOD; BURKINA FASO; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 83455178701     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-57     Document Type: Article

References (46)

1. High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication. Barbour JD, Ndhlovu LC, Xuan Tan Q, Ho T, Epling L, Bredt BM, Levy JA, Hecht FM, Sinclair E, PLoS One 2009 4 4408 10.1371/journal.pone.0004408 19198651
2. Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. Burgers WA, Riou C, Mlotshwa M, Maenetje P, de Assis Rosa D, Brenchley J, Mlisana K, Douek DC, Koup R, Roederer M, de Bruyn G, Karim SA, Williamson C, Gray CM, the CAPRISA 002 Acute Infection Study Team, J Immunol 2009 182 4751 4761 10.4049/jimmunol.0803801 19342652
3. Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project. Clerici M, Butto S, Lukwiya M, Saresella M, Declich S, Trabattoni D, Pastori C, Piconi S, Fracasso C, Fabiani M, Ferrante P, Rizzardini G, Lopalco L, AIDS 2000 14 2083 2092 10.1097/00002030-200009290-00003 11061648
4. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Begaud E, Chartier L, Marechal V, Ipero J, Leal J, Versmisse P, Breton G, Fontanet A, Capoulade-Metay C, Fleury H, Barré-Sinoussi F, Scott-Algara D, Pancino G, Retrovirology 2006 3 35 10.1186/1742-4690-3-35 16792805 (Pubitemid 44150948)
5. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation. Hazenberg MD, Otto SA, Hamann D, Roos MT, Schuitemaker H, de Boer RJ, Miedema F, AIDS 2003 17 1419 1424 10.1097/00002030-200307040-00001 12824778 (Pubitemid 36900541)
6. Immune activation is a dominant factor in the pathogenesis of African AIDS. Bentwich Z, Kalinkovich A, Weisman Z, Immunol Today 1995 16 187 191 10.1016/0167-5699(95)80119-7 7734046
7. Disease progression and survival in HIV-1-infected Africans in London. Del Amo J, Petruckevitch A, Phillips A, Johnson AM, Stephenson J, Desmond N, Hanscheid T, Low N, Newell A, Obasi A, Paine K, Pym A, Theodore CM, De Cock KM, AIDS 1998 12 1203 1209 10.1097/00002030-199810000-00013 9677170 (Pubitemid 28302423)
8. AIDS survival and progression in black Africans living in south London, 1986-1994. Low N, Paine K, Clark R, Mahalingam M, Pozniak AL, Genitourin Med 1996 72 12 16 8655159 (Pubitemid 26057868)
9. Sex, microbial translocation, and the African HIV epidemic. Lester RT, Jaoko W, Plummer FA, Kaul R, Proc Natl Acad Sci USA 2009 106 89 author reply E90 10.1073/pnas.0906913106 19706497
10. Evaluation of a simplified dual-platform flow cytometric method for measurement of lymphocyte subsets and T-cell maturation phenotypes in the population of Nouna, Burkina Faso. Böhler T, von Au M, Klose N, Müller K, Coulibaly B, Nauwelaers F, Spengler HP, Kynast-Wolf G, Kräusslich HG, Clin Vaccine Immunol 2007 14 775 781 10.1128/CVI.00043-07 17442847 (Pubitemid 47104767)
11. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint JP, Labalette M, Mech Ageing Dev 2006 127 274 281 10.1016/j.mad.2005.11.001 16352331 (Pubitemid 43214500)
12. Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Cote d'Ivoire. Ondoa P, Koblavi-Deme S, Borget MY, Nolan ML, Nkengasong JN, Kestens L, Clin Exp Immunol 2005 140 138 148 10.1111/j.1365-2249.2005.02734.x 15762885 (Pubitemid 40461083)
13. Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy. Koblavi-Deme S, Maran M, Kabran N, Borget MY, Kalou M, Kestens L, Maurice C, Sassan-Morokro M, Ekpini ER, Roels TH, Chorba T, Nkengasong JN, AIDS 2003 17 Suppl 3 17 22 14565605
14. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort. Glencross DK, Janossy G, Coetzee LM, Lawrie D, Scott LE, Sanne I, McIntyre JA, Stevens W, Cytometry B Clin Cytom 2008 74 Suppl 1 131 140 18228566
15. Activation of the CD95 system increases with disease progression in human immunodeficiency virus type 1-infected children and adolescents. Böhler T, Bäumler C, Herr I, Groll A, Kurz M, Debatin KM, Pediatr Infect Dis J 1997 16 754 759 10.1097/00006454-199708000-00005 9271036 (Pubitemid 27364786)
16. T-cell apoptosis in HIV-1-infected individuals receiving highly active antiretroviral therapy. Böhler T, Debatin KM, Wintergerst U, Blood 2001 97 1898 1901 10.1182/blood.V97.6.1898a 11263443 (Pubitemid 32217267)
17. Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection. Shepard BD, Loutfy MR, Raboud J, Mandy F, Kovacs CM, Diong C, Bergeron M, Govan V, Rizza SA, Angel JB, Badley AD, J Acquir Immune Defic Syndr 2008 48 149 155 10.1097/QAI.0b013e31816d9c3b 18360289
18. Comparison of CD4(+) T-cell subset distribution in chronically infected HIV(+) patients with various CD4 nadir counts. Sakai K, Gatanaga H, Takata H, Oka S, Takiguchi M, Microbes Infect 2010 12 374 381 10.1016/j.micinf.2010.01.013 20123036
19. Exploring pathways for memory T cell generation. Sallusto F, Lanzavecchia A, J Clin Invest 2001 108 805 806 11560949 (Pubitemid 32880290)
20. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, Nature 1999 401 708 712 10.1038/44385 10537110 (Pubitemid 29485217)
21. CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with disease progression in HIV-infected children and adolescents: effect of highly active antiretroviral therapy (HAART). Böhler T, Wintergerst U, Linde R, Belohradsky BH, Debatin KM, Pediatr Res 2001 49 101 110 10.1203/00006450- 200101000-00021 11134499 (Pubitemid 32015007)
22. Lymphocyte expression of CD95 at rest and in response to acute exercise in healthy children and adolescents. Timmons BW, Bar-Or O, Brain Behav Immun 2007 21 442 449 10.1016/j.bbi.2006.11.007 17194564 (Pubitemid 46528678)
23. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count. Tuaillon E, Al Tabaa Y, Baillat V, Segondy M, Picot MC, Reynes J, Vendrell JP, Cytometry B Clin Cytom 2009 76 249 260 19072838
24. Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand. Onlamoon N, Tabprasit S, Suwanagool S, Louisirirotchanakul S, Ansari AA, Pattanapanyasat K, Virology 2005 341 238 247 10.1016/j.virol.2005.07.018 16099011 (Pubitemid 41416733)
25. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. CDC, MMWR Recomm Rep 1993 41 RR-17 1 19 1992 Dec 18
26. Elevation of immune activation in kenyan women is associated with alterations in immune function: implications for vaccine development. Koesters SA, Matu L, Kiama P, Anzala O, Embree J, Plummer FA, Kimani J, Fowke KR, J Clin Immunol 2004 24 702 709 10.1007/s10875-004-6238-1 15622455 (Pubitemid 40933122)
27. Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Kassu A, Tsegaye A, Petros B, Wolday D, Hailu E, Tilahun T, Hailu B, Roos MT, Fontanet AL, Hamann D, De Wit TF, Clin Diagn Lab Immunol 2001 8 1171 1176 11687459 (Pubitemid 33035751)
28. Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use. Camara M, Dieye TN, Seydi M, Diallo AA, Fall M, Diaw PA, Sow PS, Mboup S, Kestens L, Jennes W, J Infect Dis 2010 201 835 842 10.1086/651000 20136413
29. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. Collenberg E, Ouedraogo T, Ganame J, Fickenscher H, Kynast-Wolf G, Becher H, Kouyate B, Kräusslich HG, Sangare L, Tebit DM, J Med Virol 2006 78 683 692 10.1002/jmv.20593 16555290
30. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. Miles DJ, van der Sande M, Jeffries D, Kaye S, Ismaili J, Ojuola O, Sanneh M, Touray ES, Waight P, Rowland-Jones S, Whittle H, Marchant A, J Virol 2007 81 5766 5776 10.1128/JVI.00052-07 17376923 (Pubitemid 46847015)
31. Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. Mueller YM, De Rosa SC, Hutton JA, Witek J, Roederer M, Altman JD, Katsikis PD, Immunity 2001 15 871 882 10.1016/S1074-7613(01)00246-1 11754810 (Pubitemid 34075369)
32. Pro- and anti-apoptotic CD95 signaling in T cells. Paulsen M, Janssen O, Cell Commun Signal 2011 9 7 10.1186/1478-811X-9-7 21477291
33. West African donors have high percentages of activated cytokine producing T cells that are prone to apoptosis. Kemp K, Akanmori BD, Hviid L, Clin Exp Immunol 2001 126 69 75 10.1046/j.1365-2249.2001.01657.x 11678901 (Pubitemid 32989494)
34. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation. Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P, Antivir Ther 2007 12 971 975 17926652 (Pubitemid 47492567)
35. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls. Lenkei R, Bratt G, Holmberg V, Muirhead K, Sandstrom E, Cytometry 1998 33 115 122 10.1002/(SICI)1097-0320(19981001)33:2<115::AID-CYTO5>3.0.CO;2- I 9773871 (Pubitemid 28447135)
36. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection. Vollbrecht T, Brackmann H, Henrich N, Roeling J, Seybold U, Bogner JR, Goebel FD, Draenert R, J Med Virol 2010 82 358 370 10.1002/jmv.21723 20087935
37. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy. Benito JM, Lopez M, Lozano S, Ballesteros C, Martinez P, Gonzalez-Lahoz J, Soriano V, J Acquir Immune Defic Syndr 2005 38 373 381 10.1097/01.qai.0000153105.42455.c2 15764953 (Pubitemid 40381546)
38. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients. Almeida M, Cordero M, Almeida J, Orfao A, Cytometry B Clin Cytom 2007 72 22 33 17051525 (Pubitemid 46105454)
39. Decreased CD95 expression on naive T cells from HIV-infected persons undergoing highly active anti-retroviral therapy (HAART) and the influence of IL-2 low dose administration. Irhan Study Group. Amendola A, Poccia F, Martini F, Gioia C, Galati V, Pierdominici M, Marziali M, Pandolfi F, Colizzi V, Piacentini M, Girardi E, D'Offizi G, Clin Exp Immunol 2000 120 324 332 10.1046/j.1365-2249.2000.01223.x 10792383 (Pubitemid 30304229)
40. Naive T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion. Di Mascio M, Sereti I, Matthews LT, Natarajan V, Adelsberger J, Lempicki R, Yoder C, Jones E, Chow C, Metcalf JA, Sidorov IA, Dimitrov DS, Polis MA, Kovacs JA, J Virol 2006 80 2665 2674 10.1128/JVI.80.6.2665-2674.2006 16501076 (Pubitemid 43346362)
41. HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso). Simpore J, Ilboudo D, Samandoulougou A, Guardo P, Castronovo P, Musumeci S, J Med Virol 2005 75 209 212 10.1002/jmv.20258 15602740 (Pubitemid 40053730)
42. Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus? Ben-Smith A, Gorak-Stolinska P, Floyd S, Weir RE, Lalor MK, Mvula H, Crampin AC, Wallace D, Beverley PC, Fine PE, Dockrell HM, BMC Infect Dis 2008 8 139 10.1186/1471-2334-8-139 18922182
43. HIV infection and hepatitis B co-infection: survey of prevalence in pregnant women in Bobo Dioulasso, Burkina Faso. Dao B, Nacro B, Dahourou H, Meda N, Van De Perre P, Rev Med Brux 2001 22 83 86 11388027 (Pubitemid 33613944)
44. Intestinal helminths: a clue explaining the low incidence of inflammatory bowel diseases in Subsaharan Africa? Potential benefits and hazards of helminth therapy. Fiasse R, Latinne D, Acta Gastroenterol Belg 2006 69 418 422 17343086
45. Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. Gopinath R, Ostrowski M, Justement SJ, Fauci AS, Nutman TB, J Infect Dis 2000 182 1804 1808 10.1086/317623 11069260
46. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, Eitan S, Stein M, Bentwich Z, Clin Exp Immunol 1998 114 414 421 10.1046/j.1365-2249.1998.00736.x 9844052 (Pubitemid 28539602)